Formula Pharmaceuticals: CoImmune Inc., a US-based clinical-stage biotech, and Formula Pharmaceutical Inc. agree to merge in an all-stock transaction

DURHAM, N.C., Jan. 15, 2020 (GLOBE NEWSWIRE) -- CoImmune, Inc. and Formula Pharmaceuticals, Inc. announced today the merger between the two companies, bringing together two therapeutic immuno-oncology platforms.